Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD)

Clinical trial NCT00151333 · COMPLETED

Trial details

NCT number: NCT00151333
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2005-02-01
Primary completion: 2005-04-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.